Laura Shawver, Capstan Therapeutics CEO

Ab­b­Vie bags Cap­stan’s in vi­vo CAR-T work with $2.1B buy­out deal

Al­most three years ago, long­time biotech vet Lau­ra Shawver cheer­ful­ly her­ald­ed the ar­rival of her lat­est start­up with a col­or­ful ob­ser­va­tion on the con­flu­ence of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.